<DOC>
	<DOCNO>NCT02965963</DOCNO>
	<brief_summary>The purpose study examine effect dopamine infusion dopamine-2 receptor blockade pulmonary capillary blood volume , diffusion , hemodynamic variable pulmonary artery pressure , cardiac output , pulmonary vascular resistance exercise . Secondarily , study examine effect dopamine infusion dopamine-2 receptor blockade exercise tolerance .</brief_summary>
	<brief_title>The Effect Dopamine Pulmonary Diffusion Capillary Blood Volume During Exercise</brief_title>
	<detailed_description>1 . Study Objectives The primary objective study examine effect dopamine infusion dopamine-2 receptor blockade pulmonary capillary blood volume , diffusion , hemodynamic variable pulmonary artery pressure , cardiac output , pulmonary vascular resistance exercise . Secondarily , study examine effect dopamine infusion dopamine-2 receptor blockade exercise tolerance . 2 . Background To meet increased oxygen demand require exercise , pulmonary diffusing capacity ( DLCO ) must increase order avoid drop arterial oxygenation early exercise termination . Enhanced DLCO exercise achieve expand pulmonary capillary blood volume ( Vc ) diffuse membrane capacity ( Dm ) recruitment distention pulmonary capillary , effectively increase surface area diffusion . Recruitment distention pulmonary capillary decrease pulmonary vascular resistance ( PVR ) , increase pulmonary blood flow ( Q ) limit rise pulmonary artery pressure ( PAP ) exercise . In health , pharmacological intervention believe affect PAP exercise . However , dopamine , pulmonary vasodilator , may help regulate PAP exercise . Specifically , dopamine appear important normal cardiovascular exercise response , Metoclopramide ( pulmonary dopamine-2-receptor antagonist ) decrease maximal Q exercise tolerance ( 1 ) . These result suggest dopamine may modulate Vc exercise via pulmonary smooth muscle regulation , subsequently affect PVR , PAP , Q exercise tolerance . However , dopamine regulates DLCO , Vc , Q , exercise tolerance unknown . Purpose : The purpose study examine effect dopamine agonist dopamine-2-receptor antagonist DLCO , Vc , PAP , PVR , Q , exercise tolerance . Hypothesis : It hypothesize dopamine increase Vc , lead reduction PVR correspond decrease PAP . This response allow increase DLCO , Q , exercise tolerance relative control . Conversely , Metoclopramide ( dopamine-2-receptor antagonist ) attenuate increase Vc well reduction PVR , lead increase PAP . In condition , DLCO , Q , exercise tolerance reduce . 3 . Methods Study Overview : This study utilize randomize , double-blind crossover design healthy subject measurement perform rest 2 workload ( 60 % 85 % previously determine VO2peak ) either intravenous dopamine ( 2µg/kg/min ) , dopamine receptor blockade ( 20mg oral Metoclopramide ) , placebo ( order randomize ) . Data collect across 5 different day 2-3 week period . Day 1 : Pulmonary function grade exercise test exhaustion . Day 2-4 : Vc determination rest exercise either intravenous dopamine , dopamine receptor blockade , placebo ( order randomize ) . Following brief period rest , time exhaustion trial 85 % VO2peak perform characterize exercise tolerance . Day 5 : Evaluation PAP via cardiac ultrasound rest exercise either intravenous dopamine , dopamine receptor blockade , placebo ( order randomize ) . Pulmonary Function &amp; Cardiopulmonary Exercise Test : Subjects undergo grade exercise test volitional exhaustion characterize aerobic fitness ( VO2peak ) standard pulmonary function test characterize lung function parameter . DLCO Vc measurement exercise : DLCO Vc measure use multiple oxygen tension DLCO breath-hold method ( 2 ) rest cycling exercise 60 % 85 % VO2peak . Over different three day , participant randomize follow condition : 1 ) dopamine ( 2 μg/kg/min intravenous ) placebo pill , 2 ) metoclopramide ( 20 mg oral ) intravenous saline , 3 ) intravenous saline placebo pill . During workload , subject perform DLCO breath-hold maneuver six second , repeat three time exercise differ oxygen tension ( 0.21 , 0.40 , 0.60; workload oxygen tension randomize ) allow calculation Vc Dm . Trials spread several day ensure CO buildup . DLCO correct hemoglobin , considerable experience performing test . Pulmonary Artery Systolic Pressure ( PASP ) , PVR , Q : Doppler echocardiography ( PASP ) use non-invasive estimate PAP dopamine condition . PASP evaluate rest exercise , method use successfully group others previous investigation ( 3,4 ) . Total PVR evaluate divide PASP Q give workload . Q evaluate use Physioflow® Impedance Cardiography ( Manatec® Biomedical ) . When compare direct Fick method , impedance cardiography provide accurate determination Q rest exercise . Hemoglobin : Since DLCO correct hemoglobin concentration , small sample blood collect via finger prick rest exercise analyze hemoglobin concentration use hand-held Hemoglobin measurement device ( HemoCue 201+ , HemoCue AB , Angelholm , Sweden ) .</detailed_description>
	<mesh_term>Metoclopramide</mesh_term>
	<mesh_term>Dopamine</mesh_term>
	<mesh_term>Dopamine Agents</mesh_term>
	<criteria>Physically active ( exercise &gt; 2 time per week ) BMI &lt; 30kg/m2 No known cardiac pulmonary disease Known cardiac pulmonary disease / abnormality Use medication could interfere dopaminergic pathway ( i.e . dopaminergic agonist / antagonist , alcohol , central nervous system depressant , serotonergic drug ) BMI &gt; 30kg/m2 Female subject must pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>